Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sofie Hellwege"'
Autor:
Sigurd Fosmark, Sofie Hellwege, Rikke H Dahlrot, Kristian L Jensen, Helene Derand, Jesper Lohse, Mia D Sørensen, Steinbjørn Hansen, Bjarne W Kristensen
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178693 (2017)
AIM:Expression of the base excision repair enzyme alkylpurine-DNA-N-glycosylase (APNG) has been correlated to temozolomide resistance. Our aim was to evaluate the prognostic value of APNG in a population-based cohort with 242 gliomas including 185 gl
Externí odkaz:
https://doaj.org/article/7584ce4144e74f5786ab29b9acefa74d
Autor:
Stine Asferg Petterson, Rikke Hedegaard Dahlrot, Sofie Hellwege, Julie A. Bangsø, Jacob Klitkou, Tine Rosenberg, Bjarne Winther Kristensen, Ann Mari Rosager, Sigurd Fosmark, Mia D. Sørensen, Steinbjørn Hansen
Publikováno v:
Dahlrot, R H, Sørensen, M D, Rosager, A M, Hellwege, S, Bangsø, J A, Rosenberg, T, Petterson, S A, Klitkou, J, Fosmark, S, Hansen, S & Kristensen, B W 2014, ' Novel approaches for quantifying protein biomarkers in gliomas : benefits and pitfalls ', C N S Oncology, vol. 3, no. 4, pp. 287-298 . https://doi.org/10.2217/cns.14.30
SUMMARY The therapeutic paradigm of gliomas is changing from a general approach towards an individualized and targeted approach. Accordingly, the search for prognostic and predictive biomarkers, as well as the demand for quantitative, feasible and ro
Autor:
Mia Dahl, Sørensen, Sigurd, Fosmark, Sofie, Hellwege, Dagmar, Beier, Bjarne Winther, Kristensen, Christoph Patrick, Beier
Publikováno v:
Advances in experimental medicine and biology. 853
Glioblastoma remains a tumor with a dismal prognosis because of failure of current treatment. Glioblastoma cells with stem cell (GSC) properties survive chemotherapy and give rise to tumor recurrences that invariably result in the death of the patien
Autor:
Christoph P. Beier, Mia D. Sørensen, Bjarne Winther Kristensen, Sigurd Fosmark, Sofie Hellwege, Dagmar Beier
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783319165363
Glioblastoma remains a tumor with a dismal prognosis because of failure of current treatment. Glioblastoma cells with stem cell (GSC) properties survive chemotherapy and give rise to tumor recurrences that invariably result in the death of the patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::597c8bd8c722040afdfe8e75136bc2a7
https://doi.org/10.1007/978-3-319-16537-0_7
https://doi.org/10.1007/978-3-319-16537-0_7
Autor:
Rikke Hedegaard Dahlrot, Sigurd Fosmark, Steinbjørn Hansen, Jesper Lohse, Bjarne Winther Kristensen, Helene Derand, Jacob v. B. Hjelmborg, Sofie Hellwege, Kristian Lindstroem Jensen
Publikováno v:
Dahlrot, R H, Hellwege, S, Fosmark, S, Jensen, K L, Lohse, J, Derand, H, von Bornemann Hjelmborg, J, Hansen, S & Kristensen, B W 2015, ' Determining viability of using APNG status as a prognostic marker in patients with glioblastoma multiforme ', Journal of Clinical Oncology, vol. 33, no. 15 suppl, 2028 . https://doi.org/10.1200/jco.2015.33.15_suppl.2028
2028 Background: Expression of the enzyme alkylpurine-DNA-N-glycosylase (APNG) has been associated with poor outcome in patients with glioblastoma multiforme (GBM). APNG is part of the base excisio...